Clinical Trials Logo

Cerebral Vasospasm clinical trials

View clinical trials related to Cerebral Vasospasm.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04208477 Completed - Clinical trials for Traumatic Brain Injury

"The Effect of Stellate Ganglion Block in Severe Brain Injury"

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Blood flow through the brain is reduced after brain damage. Secondary brain ischemia caused by hypoxia and hypotension, further increase the susceptibility of the ischemically compromised brain to secondary impairment during this period. In order to determine whether and to what extent blockage of the stellate ganglion (BSG) affects the blood flow to the injured brain, the investigators will measure the variables of brain blood flow before and after BSG using computed tomography angiography (CTA), trans-cranial Doppler ultrasound (TCD), intracranial pressure (ICP) and perfusion computed tomography (PCT) of the brain. At the same time, the investigators would like to evaluate whether and to what extent BSG affects the aseptic inflammatory brain injury response and the biochemical indicators of brain damage in patients with moderate and severe brain injury.

NCT ID: NCT03611790 Completed - Cerebral Vasospasm Clinical Trials

Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)

Start date: December 19, 2018
Phase: N/A
Study type: Interventional

The objective of the study is to assess the safety and probable benefit of the Neva VS device in patients presenting with symptomatic cerebral vasospasm despite maximal medical management following aSAH.

NCT ID: NCT03517670 Completed - Clinical trials for Subarachnoid Hemorrhage

Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm

MilriSpasm
Start date: August 31, 2020
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to evaluate the tolerance of intravenous milrinone combined to the current standard treatment for cerebral vasospasm following subarachnoid hemorrhage. Assessment of IV milrinone safety in this setting is mandatory before the conduction of a large study assessing its effectiveness.

NCT ID: NCT03214705 Completed - Clinical trials for Subarachnoid Hemorrhage

Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage

Start date: March 1, 2016
Phase:
Study type: Observational [Patient Registry]

Prospective evaluation of patients with subarachnoid hemorrhage (SAH) will be done by computed tomography angiography (CTA) and perfusion imaging (CTP) for any correlation between degree of vasospasm and perfusion deficit as well as evaluating the ability of CTP to predict delayed cerebral ischemia.

NCT ID: NCT02389634 Completed - Clinical trials for Subarachnoid Hemorrhage

Identification of Novel Molecular Markers for Vasospasm

Start date: September 2010
Phase:
Study type: Observational

The purpose of the study is to identify novel genetic and protein markers for the process of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

NCT ID: NCT02275949 Completed - Cerebral Vasospasm Clinical Trials

Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage

Start date: September 2014
Phase: N/A
Study type: Interventional

This study will evaluate acupuncture's effect of preventing vasospasm after SAH. A total of 80 participants will be recruited and will be randomized to a study group or a control group. Acupuncture, electroacupuncture and intradermal acupuncture will be done at every session in a study group, while mock transcutaneous electrical nerve stimulation(mock TENS) and sham intradermal acupuncture will be carried out in a control group.

NCT ID: NCT01799018 Completed - Clinical trials for Subarachnoid Hemorrhage

Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage

Start date: April 2011
Phase: N/A
Study type: Observational

The purpose of this study is to determine the role of Proteomics and Metallomics in Cerebral Vasospasm following Subarachnoid Hemorrhage

NCT ID: NCT01595802 Completed - Cerebral Vasospasm Clinical Trials

Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm

Start date: January 2012
Phase:
Study type: Observational

The purpose of the study is to determine the sensitivity, specificity and predictive values of the Jan Medical NeuroWave System in detecting moderate and severe vasospasm in comparison to Trans Cranial Doppler(TCD).

NCT ID: NCT01187420 Completed - Clinical trials for Subarachnoid Hemorrhage

Bilateral Bispectral Index (BIS) Study

BIS
Start date: June 2009
Phase: N/A
Study type: Observational

The purpose of this study is to assess real time changes in raw and processed EEG in relation to the clinical and radiological evidence of cerebral vasospasm.

NCT ID: NCT01158508 Completed - Clinical trials for Subarachnoid Hemorrhage

Remote Ischemic Preconditioning in Subarachnoid Hemorrhage

RIPC-SAH
Start date: April 2010
Phase: Phase 1
Study type: Interventional

Rupture of brain aneurysms is a common cause of death and disability, accounting for as many as 10% of stroke cases in the United States. While much of the resulting injury to the nervous system is caused by the initial bleeding from the aneurysm, many of these patients develop cerebral vasospasm, pathological constriction of the blood vessels supplying the brain, several days following hemorrhage. As many as a third of patients can suffer a resulting neurological deficit and stroke, presumably caused by the decreased blood flow to the brain (ischemia). This delayed brain injury accounts for a significant percentage of poor outcomes following aneurysm rupture. Studies have shown that remote ischemia to many organs can precondition other tissues (including the brain) to be more tolerant to decreases in blood flow. This "remote ischemic preconditioning" has the promise of protecting the brain from ischemic injury. Whereas in other forms of stroke the onset of ischemia cannot be predicted in the general population, following aneurysm rupture the investigators know which patients are likely to develop vasospasm and when. Therefore, ischemic preconditioning following aneurysm rupture may help prevent some of the ischemic injury caused by vasospasm. Remote ischemic preconditioning by transient limb ischemia (produced by inflation of a blood pressure cuff on the arm or leg) has been shown to minimize injury to other organs, most notably the heart. Remote ischemic preconditioning of the brain following aneurysm rupture has not yet been investigated.